332 related articles for article (PubMed ID: 29996139)
1. Prosodic Improvement in Persons with Parkinson Disease Receiving SPEAK OUT!® Voice Therapy.
Boutsen F; Park E; Dvorak J; Cid C
Folia Phoniatr Logop; 2018; 70(2):51-58. PubMed ID: 29996139
[TBL] [Abstract][Full Text] [Related]
2. An Efficacy Study of Voice Quality Using Cepstral Analyses of Phonation in Parkinson's Disease before and after SPEAK-OUT!®.
Boutsen FR; Park E; Dvorak JD
Folia Phoniatr Logop; 2023; 75(1):35-42. PubMed ID: 35817007
[TBL] [Abstract][Full Text] [Related]
3. Effects of an extended version of the lee silverman voice treatment on voice and speech in Parkinson's disease.
Spielman J; Ramig LO; Mahler L; Halpern A; Gavin WJ
Am J Speech Lang Pathol; 2007 May; 16(2):95-107. PubMed ID: 17456888
[TBL] [Abstract][Full Text] [Related]
4. Neural Correlates of Hypokinetic Dysarthria and Mechanisms of Effective Voice Treatment in Parkinson Disease.
Baumann A; Nebel A; Granert O; Giehl K; Wolff S; Schmidt W; Baasch C; Schmidt G; Witt K; Deuschl G; Hartwigsen G; Zeuner KE; van Eimeren T
Neurorehabil Neural Repair; 2018 Dec; 32(12):1055-1066. PubMed ID: 30444176
[TBL] [Abstract][Full Text] [Related]
5. Effects of intensive voice treatment (the Lee Silverman Voice Treatment [LSVT]) on vowel articulation in dysarthric individuals with idiopathic Parkinson disease: acoustic and perceptual findings.
Sapir S; Spielman JL; Ramig LO; Story BH; Fox C
J Speech Lang Hear Res; 2007 Aug; 50(4):899-912. PubMed ID: 17675595
[TBL] [Abstract][Full Text] [Related]
6. Dysarthria treatment for Parkinson's disease: one-year follow-up of SPEAK OUT!
Behrman A; Cody J; Chitnis S; Elandary S
Logoped Phoniatr Vocol; 2022 Dec; 47(4):271-278. PubMed ID: 34338571
[TBL] [Abstract][Full Text] [Related]
7. Innovative technology for the assisted delivery of intensive voice treatment (LSVT®LOUD) for Parkinson disease.
Halpern AE; Ramig LO; Matos CE; Petska-Cable JA; Spielman JL; Pogoda JM; Gilley PM; Sapir S; Bennett JK; McFarland DH
Am J Speech Lang Pathol; 2012 Nov; 21(4):354-67. PubMed ID: 23071195
[TBL] [Abstract][Full Text] [Related]
8. Intensive treatment of dysarthria secondary to stroke.
Mahler LA; Ramig LO
Clin Linguist Phon; 2012 Aug; 26(8):681-94. PubMed ID: 22774928
[TBL] [Abstract][Full Text] [Related]
9. Lee Silverman Voice Treatment for people with Parkinson's: audit of outcomes in a routine clinic.
Wight S; Miller N
Int J Lang Commun Disord; 2015; 50(2):215-25. PubMed ID: 25469736
[TBL] [Abstract][Full Text] [Related]
10. Voice in Friedreich Ataxia.
Vogel AP; Wardrop MI; Folker JE; Synofzik M; Corben LA; Delatycki MB; Awan SN
J Voice; 2017 Mar; 31(2):243.e9-243.e19. PubMed ID: 27501923
[TBL] [Abstract][Full Text] [Related]
11. The Effects of Intensive Speech Treatment on Conversational Intelligibility in Spanish Speakers With Parkinson's Disease.
Moya-Galé G; Goudarzi A; Bayés À; McAuliffe M; Bulté B; Levy ES
Am J Speech Lang Pathol; 2018 Feb; 27(1):154-165. PubMed ID: 29351354
[TBL] [Abstract][Full Text] [Related]
12. Impact of the LSVT on vowel articulation and coarticulation in Parkinson's disease.
Sauvageau VM; Roy JP; Langlois M; Macoir J
Clin Linguist Phon; 2015 Jun; 29(6):424-40. PubMed ID: 25688915
[TBL] [Abstract][Full Text] [Related]
13. The Effect of SPEAK OUT! and The LOUD Crowd on Dysarthria Due to Parkinson's Disease.
Behrman A; Cody J; Elandary S; Flom P; Chitnis S
Am J Speech Lang Pathol; 2020 Aug; 29(3):1448-1465. PubMed ID: 32421347
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of vocal symptoms in Parkinson's disease: the Lee Silverman method].
Dias AE; Limongi JC
Arq Neuropsiquiatr; 2003 Mar; 61(1):61-6. PubMed ID: 12715021
[TBL] [Abstract][Full Text] [Related]
15. A comparison of speech and language therapy techniques for dysarthria in Parkinson's disease.
Deane KH; Whurr R; Playford ED; Ben-Shlomo Y; Clarke CE
Cochrane Database Syst Rev; 2001; (2):CD002814. PubMed ID: 11406045
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic effects of intensive voice treatment (LSVT LOUD
Boliek CA; Fox CM
Int J Speech Lang Pathol; 2017 Dec; 19(6):601-615. PubMed ID: 27705010
[TBL] [Abstract][Full Text] [Related]
17. Intensive voice treatment (the Lee Silverman Voice Treatment [LSVT
Ertan E; Gürvit HI; Hanağası HH; Bilgiç B; Tunçer MA; Yılmaz C
Logoped Phoniatr Vocol; 2022 Dec; 47(4):262-270. PubMed ID: 34287100
[No Abstract] [Full Text] [Related]
18. The Lee Silverman Voice Treatment (LSVT®) speech therapy in progressive supranuclear palsy.
Sale P; Castiglioni D; De Pandis MF; Torti M; Dall'armi V; Radicati FG; Stocchi F
Eur J Phys Rehabil Med; 2015 Oct; 51(5):569-74. PubMed ID: 26138088
[TBL] [Abstract][Full Text] [Related]
19. The impact of Lee Silverman Voice Treatment (LSVT LOUD®) on voice, communication, and participation: Findings from a prospective, longitudinal study.
Bryans LA; Palmer AD; Anderson S; Schindler J; Graville DJ
J Commun Disord; 2021; 89():106031. PubMed ID: 33259945
[TBL] [Abstract][Full Text] [Related]
20. Effects of intensive voice treatment (the Lee Silverman Voice Treatment [LSVT]) on ataxic dysarthria: a case study.
Sapir S; Spielman J; Ramig LO; Hinds SL; Countryman S; Fox C; Story B
Am J Speech Lang Pathol; 2003 Nov; 12(4):387-99. PubMed ID: 14658991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
